Gilead and Merck’s latest trial success and flop - Top-Institutions - MDSpire

Gilead and Merck’s latest trial success and flop

  • By

  • Elaine Chen

  • June 9, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Sarah Cannon Research Institute
    Sarah Cannon Research Institute

    Nashville, Tennessee

    Key Differentiators

    • Oncology

  • #2

    Cleveland Clinic Lerner College of Medicine
    Cleveland Clinic Lerner College of Medicine

    Cleveland, Ohio

    Key Differentiators

    • Hematology
    • Oncology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #4

    Harvard Medical School
    Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Medicine

  • #5

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

Original Source(s)

Gilead and Merck’s latest trial success and flop

  • by Elaine Chen

  • June 9, 2026

Related Content

Feasibility of weekly patient-reported symptom monitoring using patients' own smartphones in outpatient cancer chemotherapy: the SMART-PRO study

Challenges and emerging strategies for genome-wide evaluation of loss of imprinting in cancer

Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study